Annals of Human Genetics · 2005 · 14 citations · 16 references
Life SciencesGeneticsMolecular GeneticsGenomicsMedical GeneticsNeurogeneticsDna SequencingGenetic DisordersMuscular DystrophyNeurogenetic DisordersPolymerase Chain ReactionSpinal Muscular AtrophyCarrier ScreeningDried Blood Spot AnalysisGenetic Carrier ScreeningHomozygous DeletionMultiplex Polymerase Chain Reaction (Pcr)Multiplex Polymerase Chain Reaction AssaysSmn1 Gene DeletionSpinal Muscular Atrophy Screening
Spinal muscular atrophy (SMA) is a common, often fetal, autosomal recessively inherited disease leading to progressive muscle wasting and paralysis as a result of degeneration of anterior horn cells of the spinal cord. The SMA-determining gene, called the survival of motor neuron gene (SMN), is present on 5q13 in two nearly identical copies, telomeric SMN (SMN1) and centromeric SMN (SMN2). It has been established that SMA is caused by mutations in SMN1 whereas homozygous deletion of SMN2 has apparently no pathological consequences. The aim of this study is to develop an easy and inexpensive method for the isolation of high-quality template DNA from blood samples for SMA carrier screening by multiplex polymerase chain reaction. We have developed a protocol that optimizes detection of the SMN1 copy number in the human genome, producing a specific and sensitive assay using DNA extracted from a dried blood spot on IsoCode paper.
16
Markus Feldkötter, Verena Schwarzer, Radu Wirth et al. · The American Journal of Human Genetics · 2002 · 1K citations · Full text
Patricia McAndrew, D. Williams Parsons, Louise R. Simard et al. · The American Journal of Human Genetics · 1997 · 533 citations · Full text